hey @TimmyR30 perhaps novartis is just waiting on read outs on the many biomarkers before re-committing to this indication ...SI has not said they are giving up on Covid Ards...
yes novartis collaboration /partnership looks like focus is switching to non-covid ards but if results of our covid ards are promising there is always a chance we could see some sort of emergency approval...( afterall covid is not going away anytime soon)
A Non-covid ards trial if successful, could also open up the covid ards market via a label extension and we would have a more consistant cohort of patients ( as opposed to rapidly changing cohort during our recent trials ford covid ards)
but i will not right off our chances for an eventual approval in covid ards ....
- Forums
- ASX - By Stock
- MSB
- Ann: Appendix 4C Quarterly Activity Report
Ann: Appendix 4C Quarterly Activity Report, page-76
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B |
Open | High | Low | Value | Volume |
$1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 19746 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.205 |
2 | 55500 | 1.200 |
3 | 60292 | 1.195 |
1 | 33180 | 1.190 |
3 | 67965 | 1.185 |
Price($) | Vol. | No. |
---|---|---|
1.210 | 19746 | 3 |
1.215 | 45236 | 7 |
1.220 | 190559 | 15 |
1.225 | 70181 | 4 |
1.230 | 169274 | 5 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
BM8
BATTERY AGE MINERALS LTD
Nigel Broomham, CEO
Nigel Broomham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online